Arch Biopartners Inc. (TSXV: ARCH)
Canada
· Delayed Price · Currency is CAD
1.950
+0.020 (1.04%)
Nov 22, 2024, 3:59 PM EST
Arch Biopartners Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
Cash & Equivalents | 0.04 | 0.83 | 0.51 | 0.45 | 0.65 | 0.4 | Upgrade
|
Cash & Short-Term Investments | 0.04 | 0.83 | 0.51 | 0.45 | 0.65 | 0.4 | Upgrade
|
Cash Growth | -96.85% | 64.17% | 12.96% | -31.43% | 63.27% | -26.45% | Upgrade
|
Accounts Receivable | 0.97 | - | - | 1.85 | - | 0.03 | Upgrade
|
Other Receivables | 0.5 | 0.3 | 0.09 | 0.35 | 0.06 | 0.11 | Upgrade
|
Receivables | 1.46 | 0.3 | 0.09 | 2.2 | 0.06 | 0.14 | Upgrade
|
Prepaid Expenses | 0.03 | 0.04 | 0.03 | 0.02 | 0.03 | 0.29 | Upgrade
|
Total Current Assets | 1.54 | 1.17 | 0.62 | 2.67 | 0.74 | 0.83 | Upgrade
|
Total Assets | 1.54 | 1.17 | 0.62 | 2.67 | 0.74 | 0.83 | Upgrade
|
Accounts Payable | 2.66 | 0.39 | 0.49 | 0.96 | 0.95 | 0.47 | Upgrade
|
Accrued Expenses | 0.12 | 0.17 | 0.19 | 0.42 | 0.27 | 0.12 | Upgrade
|
Short-Term Debt | 2.21 | 1.71 | - | 1.8 | - | - | Upgrade
|
Current Portion of Long-Term Debt | 2.61 | 2.6 | 2.1 | - | - | - | Upgrade
|
Current Unearned Revenue | - | 1.1 | - | - | - | - | Upgrade
|
Total Current Liabilities | 7.6 | 5.98 | 2.78 | 3.19 | 1.22 | 0.58 | Upgrade
|
Long-Term Debt | 0.5 | 0.7 | 2.31 | 3.36 | 3.39 | 2.89 | Upgrade
|
Total Liabilities | 8.1 | 6.68 | 5.09 | 6.55 | 4.61 | 3.47 | Upgrade
|
Common Stock | 16.82 | 15.88 | 15.55 | 14.76 | 13.71 | 12.03 | Upgrade
|
Additional Paid-In Capital | 7.49 | 6.66 | 4.7 | 4.68 | 4.57 | 2.84 | Upgrade
|
Retained Earnings | -30.87 | -28.05 | -24.72 | -23.32 | -22.15 | -17.52 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | - | 0.02 | Upgrade
|
Shareholders' Equity | -6.56 | -5.51 | -4.47 | -3.88 | -3.87 | -2.64 | Upgrade
|
Total Liabilities & Equity | 1.54 | 1.17 | 0.62 | 2.67 | 0.74 | 0.83 | Upgrade
|
Total Debt | 5.32 | 5.02 | 4.41 | 5.16 | 3.39 | 2.89 | Upgrade
|
Net Cash (Debt) | -5.28 | -4.18 | -3.91 | -4.72 | -2.74 | -2.48 | Upgrade
|
Net Cash Per Share | -0.08 | -0.07 | -0.06 | -0.08 | -0.05 | -0.04 | Upgrade
|
Filing Date Shares Outstanding | 64.65 | 62.76 | 62.4 | 61.36 | 61.36 | 59.88 | Upgrade
|
Total Common Shares Outstanding | 64.25 | 62.6 | 62.33 | 61.96 | 60.78 | 58.96 | Upgrade
|
Working Capital | -6.06 | -4.81 | -2.16 | -0.52 | -0.48 | 0.25 | Upgrade
|
Book Value Per Share | -0.10 | -0.09 | -0.07 | -0.06 | -0.06 | -0.04 | Upgrade
|
Tangible Book Value | -6.56 | -5.51 | -4.47 | -3.88 | -3.87 | -2.64 | Upgrade
|
Tangible Book Value Per Share | -0.10 | -0.09 | -0.07 | -0.06 | -0.06 | -0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.